Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Handbook of Clinical Neurology|April 27, 2016
Cellular, synaptic, and circuit effects of antibodies in autoimmune CNS synaptopathiesAnkit Jain, Rita Balice-GordonNeuron|November 29, 2008
New dogs in the dogma: Lrp4 and Tid1 in neuromuscular synapse formationYuanquan Song, Rita Balice-GordonNeuron|December 3, 2014
Rigor or mortis: best practices for preclinical research in neuroscienceOswald Steward, Rita Balice-GordonThe Lancet. Neurology|December 18, 2010
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisJosep Dalmau, Eric Lancaster, Eugenia Martinez-Hernandez, et al.Journal of Psychopharmacology (Oxford, England)|July 3, 2019
A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophreniaEstibaliz Arce, Rita Balice-Gordon, Sridhar Duvvuri, et al.The Lancet. Neurology|June 29, 2010
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case seriesMeizan Lai, Maartje G M Huijbers, Eric Lancaster, et al.Neuron|June 3, 2016
Neuroscience Training for the 21st CenturyHuda Akil, Rita Balice-Gordon, David Lopes Cardozo, et al.Frontiers in Aging Neuroscience|December 13, 2021
The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus MonkeyTara L Moore, Damon A Young, Ronald J Killiany, et al.Neurology|August 16, 2013
Late-onset anti-NMDA receptor encephalitisMaarten J Titulaer, Lindsey McCracken, Iñigo Gabilondo, et al.The Lancet. Neurology|October 15, 2008
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesJosep Dalmau, Amy J Gleichman, Ethan G Hughes, et al.Pageof 3